Chiesi Farmaceutici has been awarded with the "Special Mention fro innovation" for Holoclar, during the ceremony of the Galeno Award, a prize promoting the most important progresses in the pharmaceutical research. The Galeno Award is considered today the Nobel prize in the Pharmaceutical area and the highest recognition for research and development in this field. The scientific commitee, chaired by Professor Pier Luigi Canonico, of the Department of Drug Science of the University of Piemonte Orientale, has decided to award Holovlr with a special mention, considering its high innovation value for the treatment with stem cells.
The recognition was given to Giuseppe Chiericatti, Corporate Marketing Head and Alessandra Madoni, Market Access Head, who participated on behalf of Cheisi Farmaceutici.
"Research and innovation are the main engine of growth and development of scientific know-how." commented Prof Canonico, "Chiesi confirms today its strong tradition in the pharmaceutical innovation also thanks to Holoclar".
For more information on Holoclar:
For more inofrmation on the collaboration with Holostem
For mre inofrmation on the Galeno Award: